Clinical trials: Slipped Capital Femoral Epiphyses

Hip Osteoarthritis

OXINIUM◊ DH Total Hip Arthroplasty Pivotal Study

• Active, not recruiting
• Age: 22 to 79 years
• Medical device
• Results posted

The purpose of this study is to monitor safety of the participants implanted with the OXINIUM◊ DH Hip System up to 10-years post-implantation

Trial name

NCT02353377

Testing

OXINIUM DH Hip System, BIOLOX◊

Volunteers

413 people

Sponsor

Smith & Nephew, Inc.